Heart Failure Treatment Options and Clinical Trials | Ancora Heart
WEBAccuCinch is a breakthrough device for heart failure patients with reduced ejection fraction. It is a percutaneous therapy that aims to improve quality of life, functional capacity and reverse remodeling.
ANCORA HEART’S ACCUCINCH SYSTEM DEMONSTRATES …
WEBThe AccuCinch System is a transcatheter device-based therapy to address heart failure (HF) by reducing the enlarged left ventricle. The 12-month data show significant improvement in quality of life, functional capacity, ejection fraction and reverse remodeling in …
Ancora Heart Receives Breakthrough Device Designation from …
WEBAncora Heart is developing a transcatheter therapy to improve the structure and function of the enlarged left ventricle in heart failure patients. The AccuCinch System has received Breakthrough Device Designation from the FDA and …
Randomized Clinical Evaluation of the AccuCinch® Ventricular ...
WEBJun 9, 2024 · The CORCINCH-HF Study is evaluating the safety and efficacy of the AccuCinch® Ventricular Restoration System, a new and innovative device-based approach to treating heart failure that is designed to improve the structure and function of the heart and may help reduce symptoms, improve quality of …
Percutaneous Mitral Valve Therapies: The Old, Current, and Future
WEBJul 31, 2020 · The AccuCinch system is designed to treat functional MR and LV remodeling by decreasing the circumference of the dilated LV, reducing its radius and reducing the mitral valve annulus dimensions. The device consists of anchors with self-expanding nitinol arms that fix the anchor into the myocardium.
AccuCinch® Ventricular Restoration System - Oklahoma Heart …
WEBMar 10, 2023 · The AccuCinch System is a new therapy for patients with heart failure who do not respond to current medical care. It is placed in the left ventricle through a catheter and reduces the size of the heart to improve pumping efficiency.
Ancora Heart AccuCinch - Business Wire
WEBNov 8, 2021 · Ancora Heart's proprietary AccuCinch® Ventricular Restoration System is the only completely transcatheter device designed to restore the structure and function of the enlarged left ventricle of...
Ancora Heart’s AccuCinch Ventricular Restoration System …
WEBJul 12, 2022 · The AccuCinch system is designed to provide a minimally invasive treatment option for patients with symptomatic heart failure (HF) with reduced ejection fraction (HFrEF).
Transcatheter Left Ventricular Restoration in Patients With Heart ...
WEBFeb 28, 2023 · In patients with heart failure with reduced ejection fraction without significant mitral regurgitation receiving optimal medical therapy, the AccuCinch System resulted in decreases of LV volume, as well as improved quality of life and exercise endurance. A randomized trial is ongoing (NCT04331769).
FDA Gives Breakthrough Device Designation to Ancora Heart’s AccuCinch
WEBJul 18, 2022 · The FDA granted Santa Clara, Calif.-based Ancora Heart a Breakthrough Device designation for its AccuCinch ventricular restoration system. The device is intended to provide a minimally invasive treatment option for patients who have symptomatic heart failure with reduced ejection fraction.
Skip to content